Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Operating Expenses | 58,966 | 63,627 | 70,810 | 65,110 | 51,611 |
| Operating Income | -58,966 | -63,627 | -70,810 | -65,110 | -51,611 |
| Other Income | 395 | 609 | 1,215 | 1,542 | 2,124 |
| Pre-tax Income | -58,571 | -63,018 | -69,595 | -63,568 | -49,487 |
| Net Income Continuous | -58,571 | -63,018 | -69,595 | -63,568 | -49,487 |
| Net Income | $-58,571 | $-63,018 | $-69,595 | $-63,568 | $-49,487 |
| EPS Basic Total Ops | -0.40 | -0.47 | -0.55 | -0.51 | -0.40 |
| EPS Basic Continuous Ops | -0.40 | -0.47 | -0.55 | -0.51 | -0.40 |
| EPS Diluted Total Ops | -0.40 | -0.47 | -0.55 | -0.51 | -0.40 |
| EPS Diluted Continuous Ops | -0.40 | -0.47 | -0.55 | -0.51 | -0.40 |
| EBITDA(a) | $-58,283 | $-63,334 | $-70,608 | $-65,202 | $-51,901 |